The inhalation toxicity of two commercial dyes: solvent yellow 33 and solvent green 3. 1987

J D Sun, and R F Henderson, and T C Marshall, and Y S Cheng, and J S Dutcher, and J A Pickrell, and J L Mauderly, and F F Hahn, and D A Banas, and F A Seiler

The quinoline dye 2-(2'-quinolyl)-1,3-indandione or Solvent Yellow 33 (SY) and the anthraquinone dye 1,4-di-p-toluidinoanthraquinone or Solvent Green 3 (SG) are used in many manufactured products including military smoke grenades. During manufacturing, SY or a combination of both SY and SG can be released into the air, exposing factory workers by inhalation to these dye compounds. The potential inhalation toxicity of these compounds was tested by exposing F344/N rats to different concentrations of SY or SY/SG dye mixture (30:70 w/w) for 6 hr/day, 5 days/week for 4 or 13 weeks. In the 4-week studies, rats were exposed to SY aerosols at average concentrations of 10 +/- 5, 51 +/- 10, or 230 +/- 30 mg/m3 (means +/- SD) or SY/SG aerosols at average concentrations of 11 +/- 5, 49 +/- 11, or 210 +/- 50 mg/m3 (means +/- SD). Rats exposed to the highest concentration of SY or SY/SG had body weights that were approximately 8% or 7% less, respectively, than their controls after exposure. Rats exposed to the highest concentration of SY/SG for 4 weeks also had reduced pulmonary gas exchange efficiency, airflow obstruction, mild pulmonary inflammation, slight Type II pulmonary epithelial cell hyperplasia, and proliferation of vacuolated alveolar macrophages. In the 13-week studies, rats were exposed to SY aerosols at average concentrations of 1.0 +/- 0.2, 10.8 +/- 1.8, or 100 +/- 17 mg/m3 (means +/- SD) or SY/SG aerosols at average concentrations of 1.1 +/- 0.5, 10.2 +/- 3.1, or 101 +/- 23 mg/m3 (means +/- SD). Animals exposed to the highest concentration of SY or SY/SG for 13 weeks had body weights that were approximately 5 or 9% less, respectively, than their controls after exposure and had accumulation of vacuolated alveolar macrophages in lungs. Rats exposed to the highest concentration of SY/SG dye mixture for 13 weeks also had indications of mild pulmonary inflammation and slight Type II pulmonary epithelial cell hyperplasia. Very little SY was found in lungs after any exposures, indicating its clearance from lungs was at a rapid rate. However, significant amounts of the SG component of the SY/SG mixture were detected in lungs after each exposure. Lung clearance half-times of SG from the 13-week exposure were estimated to be approximately 280 days. In summary, neither test material appeared to be highly toxic following inhalation. However, the slightly higher toxicity observed for SY/SG over SY alone is probably related to the longer lung retention of the SG component of the dye mixture.

UI MeSH Term Description Entries
D007507 Therapeutic Irrigation The washing of a body cavity or surface by flowing water or solution for therapy or diagnosis. Douching,Lavage,Douchings,Irrigation, Therapeutic,Irrigations, Therapeutic,Lavages,Therapeutic Irrigations
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D011804 Quinolines
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D005260 Female Females
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000880 Anthraquinones Compounds based on ANTHRACENES which contain two KETONES in any position. Substitutions can be in any position except on the ketone groups. Anthracenedione,Anthracenediones,Anthranoid,Anthraquinone,Anthraquinone Compound,Anthraquinone Derivative,Dianthraquinones,Dianthrones,Anthranoids,Anthraquinone Compounds,Anthraquinone Derivatives,Compound, Anthraquinone,Derivative, Anthraquinone
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor

Related Publications

J D Sun, and R F Henderson, and T C Marshall, and Y S Cheng, and J S Dutcher, and J A Pickrell, and J L Mauderly, and F F Hahn, and D A Banas, and F A Seiler
March 1987, Journal of chromatography,
J D Sun, and R F Henderson, and T C Marshall, and Y S Cheng, and J S Dutcher, and J A Pickrell, and J L Mauderly, and F F Hahn, and D A Banas, and F A Seiler
August 1984, Human toxicology,
J D Sun, and R F Henderson, and T C Marshall, and Y S Cheng, and J S Dutcher, and J A Pickrell, and J L Mauderly, and F F Hahn, and D A Banas, and F A Seiler
July 1986, Fundamental and applied toxicology : official journal of the Society of Toxicology,
J D Sun, and R F Henderson, and T C Marshall, and Y S Cheng, and J S Dutcher, and J A Pickrell, and J L Mauderly, and F F Hahn, and D A Banas, and F A Seiler
March 1978, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
J D Sun, and R F Henderson, and T C Marshall, and Y S Cheng, and J S Dutcher, and J A Pickrell, and J L Mauderly, and F F Hahn, and D A Banas, and F A Seiler
August 1950, Die Pharmazie,
J D Sun, and R F Henderson, and T C Marshall, and Y S Cheng, and J S Dutcher, and J A Pickrell, and J L Mauderly, and F F Hahn, and D A Banas, and F A Seiler
April 2000, Contact dermatitis,
J D Sun, and R F Henderson, and T C Marshall, and Y S Cheng, and J S Dutcher, and J A Pickrell, and J L Mauderly, and F F Hahn, and D A Banas, and F A Seiler
January 1971, Bulletin de la Societe francaise de dermatologie et de syphiligraphie,
J D Sun, and R F Henderson, and T C Marshall, and Y S Cheng, and J S Dutcher, and J A Pickrell, and J L Mauderly, and F F Hahn, and D A Banas, and F A Seiler
May 1987, American Industrial Hygiene Association journal,
J D Sun, and R F Henderson, and T C Marshall, and Y S Cheng, and J S Dutcher, and J A Pickrell, and J L Mauderly, and F F Hahn, and D A Banas, and F A Seiler
April 2001, Bulletin of environmental contamination and toxicology,
J D Sun, and R F Henderson, and T C Marshall, and Y S Cheng, and J S Dutcher, and J A Pickrell, and J L Mauderly, and F F Hahn, and D A Banas, and F A Seiler
July 2016, Toxicological research,
Copied contents to your clipboard!